Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 2, 2009, Pages 200-210

  de Luca, Giuseppe ^a,b   Valgimigli, Marco ^c   Spaulding, Christian ^d   Menichelli, Maurizio ^e   Brunner La Rocca, Hans Peter ^f   van der Hoeven, Bas L ^g   Di Lorenzo, Emilio ^h   de la Llera, Luis S Diaz ⁱ   Pasceri, Vincenzo ^j   Pittl, Undine ^f   Percoco, Gianfranco ^c   Violini, Roberto ^e   Stone, Gregg W ^k  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Division of Cardiology   (Italy)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j SAN FILIPPO NERI HOSPITAL   (Italy)

^k NewYork Presbyterian Hospital   (United States)

more..

Author keywords

Meta analysis; Myocardial Infarction; Primary angioplasty; Randomized trial; SES

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN; TIROFIBAN;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG SAFETY; HEART REINFARCTION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION; STENT THROMBOSIS; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; ANTIBIOTICS, ANTINEOPLASTIC; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SIROLIMUS; THROMBOSIS;

EID: 67849128704     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0305-7     Document Type: Article

References (38)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C et al (2003) SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323. doi: 10.1056/NEJMoa035071
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT et al (2004) TAXUS-IV Investigators; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231. doi: 10.1056/NEJMoa032441
3. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A et al (2004) SES-SMART Investigators. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: A randomized trial. JAMA 292:2727-2734. doi: 10.1001/jama.292.22.2727
4. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V et al (2004) Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109:1244-1249. doi: 10.1161/ 01.CIR.0000118474.71662.E3
5. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G (2006) Drug eluting stents: An updated meta-analysis of randomised controlled trials. Heart 92:641-649. doi: 10.1136/hrt.2005.061622
6. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519-1521. doi: 10.1016/S0140-6736(04)17275-9
7. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126-2130. doi: 10.1001/ jama.293.17.2126
8. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L, SCAAR Study Group (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009-1019. doi: 10.1056/NEJMoa067722
9. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS et al (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation 113:2803-2809. doi: 10.1161/ CIRCULATIONAHA.106.618066
10. Kernis SJ, Cohen D, Rein K (2005) Clinical outcome associated with use of drug-eluting stents compared with bare metal stent for primary percutaneous intervention. Am J Cardiol 96(suppl 7A):47H
11. Daemen J, Tanimoto S, Garcia-Garcia HM, Kukreja N, van de Sande M, Sianos G et al (2007) Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99:1027-1032. doi: 10.1016/j.amjcard.2006.11.070
12. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A (2007) Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28:2706-2713. doi: 10.1093/eurheartj/ ehm402
13. De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U, Violini R, Percoco G, Marino P (2008) Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. Int J Cardiol, Apr 2 [Epub ahead of print]
14. Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A (2007) A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50:1373-1380. doi: 10.1016/j.jacc.2007.06.047
15. Egger M, Smith GD (1998) Bias in location and selection of studies. BMJ 31:61-66
16. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354:1896-1900. doi: 10.1016/S0140-6736(99)04149-5
17. Valgimigli M, Bolognese L, Anselmi M, Campo G, Rodriguez AE, de Cesare N et al (2005) Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: A randomized trial. JAMA 293:2109-2117. doi: 10.1001/jama.293.17.2109
18. Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T et al (2006) Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355:1105-1113. doi: 10.1056/NEJMoa062598
19. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D et al (2006) TYPHOON investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355:1093-1104. doi: 10.1056/NEJMoa062006
20. Di Lorenzo E, Varricchio A, Lanzillo T (2005) Paclitaxel and Sirolimus stent implantation in patients with acute myocardial infarction. Circulation 112(Abstract Suppl):II-478
21. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M et al (2007) Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 49:1924-1930. doi: 10.1016/j.jacc.2007.01.081
22. Pittl U, Kaiser C, Brunner-La Rocca HP (2006) BASKET Investigators. Safety and efficacy of drug eluting stents versus bare metal stents in primary angioplasty of patients with acute ST-elevation myocardial infarction - a prospective randomized study. Eur Heart J 27(Abstract Suppl):650
23. Sardella G, Paroli M, Mancone M (2006) Impact of paclitaxel-eluting stent implantation in patients with STEMI on anti-inflammatory IL-10-producing T regulatory 1 (Tr1) cells. Eur Heart J 27(Abstract Suppl):831
24. Pasceri V, Granatelli A, Pristipino C (2003) A randomized trial of a rapamycin-eluting stent in acute myocardial infarction: Preliminary results. Am J Cardiol 92(Suppl 6A):1L
25. Tierala I (2005) The Helsinki area acute myocardial infarction treatment re-evaluation - Should the patient get a drug-eluting or a normal stent (HAAMU-STENT) study. http://www.tctmd.com/csportal/appmanager/tctmd/ main?_nfpb=true&_pagelLabel=TCTMDContent&hdCon=1453095
26. van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ (2008) Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention study. J Am Coll Cardiol 51:618-626. doi: 10.1016/j.jacc.2007.09.056
27. Díaz de la Llera LS, Ballesteros S, Nevado J, Fernández M, Villa M, Sánchez A, Retegui G, García D, Martínez A (2007) Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty. Am Heart J 154:164.e1-164.e6
28. Chechi T, Vittori G, Biondi Zoccai GG, Vecchio S, Falchetti E, Spaziani G, Baldereschi G, Giglioli C, Valente S, Margheri M (2007) Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 20:282-291. doi: 10.1111/j.1540-8183.2007.00270.x
29. Kelbæk H, Thuesen L, Helqvist S et al (2008) Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: Eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 118:1155-1162
30. Karjalainen PP, Ylitalo A, Niemelä M et al (2008) Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: A 12-months follow-up report from the TITAX AMI trial. EuroIntervention 4:234-241
31. Valgimigli M, Campo G, Percoco G, Bolognese L, Vassanelli C, Colangelo S, de Cesare N, Rodriguez AE, Ferrario M, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro MS, Parrinello G, Ferrari R, for the Multicentre Evaluation of Single High-Dose Bolus Tirofiban vs Abciximab With Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators (2008) Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: The MULTISTRATEGY randomized trial. JAMA, Mar 30 [Epub ahead of print]
32. Stone GWA (2008) Prospective, randomized comparison of paclitaxel-eluting TAXUS stents vs. bare metal stents during primary angioplasty in acute myocardial infarction- One year results of HORIZONS AMI. http://www.clinicaltrialresults.org/. Accessed 18 Oct 2008
33. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, Chiariello M, Marino P (2008) Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials. Int J Cardiol 126:37-44
34. Suryapranata H, De Luca G, van't Hof AW, Ottervanger JP, Hoorntje JC, Dambrink JH et al (2005) Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomized comparison in a large unselected cohort of patients. Heart 91:641-645. doi: 10.1136/ hrt.2004.056705
35. De Luca G, Ernst N, van't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT et al (2006) Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 151:1256-1259. doi: 10.1016/ j.ahj.2005.06.047
36. Ruygrok PN, Melkert R, Morel MA et al (1999) Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators. J Am Coll Cardiol 34:1507-1511. doi: 10.1016/ S0735-1097(99)00380-0
37. Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C et al (2006) TAXUS-IV investigators. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: Results from the TAXUS-IV trial. J Am Coll Cardiol 48:32-36. doi: 10.1016/ j.jacc.2006.02.060
38. Bainey KR, Norris CM, Graham MM, Ghali WA, Knudtson ML, Welsh RC, For the APPROACH investigators (2008) Clinical in-stent restenosis with bare metal stents: Is it truly a benign phenomenon? Int J Cardiol 128:378-382